Where Russia reported positive results of the 2nd phase trials for vaccine Sputnik-V on healthy adults, the vaccine is ready for its 3rd phase trials. Sputnik-V is developed by Gamaleya Research Institute in Russia, approved by Ministry of Health of the Russian federation. India showed interest in conducting 3rd phase trials in the country. Reportedly, vaccine will be available in India from the month of september that gives hopes to the Covid-19 patients. 20 countries, including India are interested in conducting the trials. Results will be reported online in the month of October or November.